← brief for 2026-08-13 · Slowing decline

Finding the sweet spot in green nephrology: the intersection of environmental sustainability and excellence in patient care.

Article B Peer reviewed Small trial

Key takeaways

A review of 10 studies found that using bisphosphonates or denosumab did not affect kidney function. This group had higher-than-average cardiovascular risk.

Who did this work

Murea M · Mortimer F · Demirtas G · Seman A · Picillo R · de Barbieri I · Woywodt A · Piccoli GB

Source

Article · PubMed, CKD progression and prevention · 2026 Jun 12
https://pubmed.ncbi.nlm.nih.gov/42582857/